Concurrent Treatment with Vitamin K2 and D3 on Spine Fusion in Patients with Osteoporosis-Associated Lumbar Degenerative Disorders.
- 2021-12-15
- Clinical Trial
- Spine 47(4)
- Wencan Zhang
- Le Li
- Xin Zhou
- Kunpeng Li
- Chen Liu
- Xiangyu Lin
- Njabulo Lubisi
- Junfei Chen
- Haipeng Si
- PubMed: 34919073
- DOI: 10.1097/brs.0000000000004309
- Moderate evidence
- Clinical
At six months postoperatively, complete fusion rates were significantly higher in the VK2+VD3 group than that in the control group (91.18% vs 71.43%, P = 0.036).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes